[Granuloma formation in test and treatment sites caused by intracutaneously administered, injectable collagen].
Within 24 h of intracutaneous administration of an injectable collagen implant, a 34-year-old woman developed reddish-yellow nodules at two test implantation sites as well as at treatment sites. These nodules have persisted for more than 8 months. Histological findings seem to be consistent with an allergic reaction of the granulomatous type (type V).
D000328:Adult; D003094:Collagen / Q000009:adverse effects*; D003875:Drug Eruptions / Q000473:pathology*; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006099:Granuloma / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007279:Injections, Subcutaneous; D007428:Intradermal Tests; D019736:Prostheses and Implants; D012867:Skin / Q000473:pathology
D003094:Collagen
Granulombildung an Test- und Behandlungsstellen durch intrakutan verabreichtes, injizierbares Kollagen.